 |
FDA Approval Activities for this Drug
POTASSIUM CHLORIDE Tablet, Extended Release; 10MEQ KLOR-CON Upsher Smith
019123 POTASSIUM CHLORIDE Tablet, Extended Release; 8MEQ KLOR-CON Upsher Smith
074726 POTASSIUM CHLORIDE Tablet, Extended Release; 10MEQ KLOR-CON M10 Upsher Smith
074726 POTASSIUM CHLORIDE Tablet, Extended Release; 15MEQ KLOR-CON M15 Upsher Smith
074726 POTASSIUM CHLORIDE Tablet, Extended Release; 20MEQ KLOR-CON M20 Upsher Smith Klor-Con (potassium chloride) Extended-release Tablets, Upsher-Smith Laboratories Potassium Chloride, Baxter Healthcare Potassium Chloride, Baxter Healthcare Potassium Chloride, Baxter Healthcare Potassium Chloride Extended-Release Tablets, Eurand, Approval | Potassium Chloride in Dextrose and Sodium Chloride Injection, B. Braun, Labeling Revision
| Potassium Chloride in Sodium Chloride Injection, B. Braun, Labeling Revision
| Potassium Chloride in Dextrose Injection, B. Braun, Labeling Revision | Slow-K (potassium chloride) Extended-Release Tablets, Novartis Pharma, Labeling Revision | K-Tab (potassium chloride) Extended-Release Tablets, Abbott, Labeling Revision
For the latest approval information, please locate this drug using this index.
|